Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with GILD as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|12.25%||Market Vectors Biotech ETF (BBH)||+20.57 (17.83%)|
|7.03%||iShares Nasdaq Biotechnology Index Fund (IBB)||+63.61 (20.97%)|
|5.42%||SPDR Select Sector Fund - Health Care (XLV)||+6.70 (9.80%)|
|5.23%||iShares U.S. Healthcare ETF (IYH)||+15.24 (10.57%)|
|4.78%||PowerShares Dynamic Pharmaceuticals (PJP)||+11.16 (16.77%)|
Company Description (as filed with the SEC)
Gilead Sciences, Inc. (Gilead, we or us), incorporated in Delaware on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's primary areas of focus include human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, oncology and inflammation, and serious cardiovascular and respiratory conditions. We have operations in more than 30 countries worldwide, with headquarters in Foster City, California. We continue to add to our existing portfolio of products through our internal discovery and clinical development programs and through a product acquisition and in-licensing strategy. ... More ...
Where does GILD fit in the risk graph?
|Annual EPS Est:||$7.91|
|Quarterly EPS Est:||2.83|